Maria Stefania De Propris

4PUBLICATIONS
15CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 11, 2026
Dynamics of in vivo immune remodeling in Ph+ all patients receiving frontline ponatinib and blinatumomab therapy.

|Jan 22, 2026
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia.

Michela Ansuinelli, Nadia Peragine, Maria Stefania De Propris

|Nov 28, 2025
Managing Treatment-Emergent Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Following CAR-T Cell Therapy: A Case-Based Review of the use of Emapalumab.

Livia Donzelli, Veronica Zullino, Giovanni Fernando Torelli

|Apr 28, 2025
CD99 expression in acute myeloid leukemia with FLT3 internal tandem duplications (FLT3-ITDmut-AML): a flow-cytometric marker for an accurate diagnostic workup.

Alessandro Laganà, Deborah Kasmi, Daniela Diverio

Pageof 1

Frequent Collaborators

2 joint publications

Michela Ansuinelli

2 joint publications

Robin Foà

1 joint publications

Alessandro Laganà

1 joint publications

Massimo Breccia